• Dr H. Onno Ruding (chairman)
    Dr H. Onno Ruding (chairman)Chairman of CEPS, Retired Vice Chairman of Citibank, Former Dutch Minister of Finance, The Hague, The Netherlands
    • Prof. Sander van Deventer
      Prof. Sander van DeventerFounder and managing partner of Forbion Capital Partners Professor in Translational Gastroenterology at the University of Leiden The Netherlands
      • Dr Michel Goldman
        Dr Michel GoldmanFull Professor at Université Libre de Bruxelles, Formerly IMI Executive Director Brussels, Belgium
        • Prof. Paul-Henri Lambert
          Prof. Paul-Henri LambertDirector International Advanced Course of Vaccinology University of Geneva Geneva, Switzerland
          • Prof. Georg Friedrich (Fritz) Melchers
            Prof. Georg Friedrich (Fritz) MelchersProfessor of Immunology University of Basel, Senior Research Group Leader Max Planck- Institute for Infection Biology, co-founder 4-Antibody Berlin, Germany
            • Prof. Douglas B. Young
              Prof. Douglas B. YoungFleming Professor of Medical Microbiology, Imperial College London, Group leader at the Francis Crick Institute, London, United Kingdom
              • Anna Koivuniemi
                Anna KoivuniemiPartner, McKinsey & Company, Amsterdam, the Netherlands
                • Dr. Carole Heilman
                  Dr. Carole HeilmanFormer Director of the Division of Microbiology and Infectious Diseases (DMID), at the National Institute of Allergy and Infectious Diseases (NIAID), USA